Literature DB >> 10609527

Visceral leishmaniasis in clinical practice.

R N Davidson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609527     DOI: 10.1016/s0163-4453(99)90001-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  9 in total

1.  Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.

Authors:  P Escobar; V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.

Authors:  K C Carter; A B Mullen; S Sundar; R T Kenney
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Flow cytometric detection of Leishmania parasites in human monocyte-derived macrophages: application to antileishmanial-drug testing.

Authors:  C Di Giorgio; O Ridoux; F Delmas; N Azas; M Gasquet; P Timon-David
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

4.  Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation.

Authors:  Yegnasew Takele; Emebet Adem; Susanne Ursula Franssen; Rebecca Womersley; Myrsini Kaforou; Michael Levin; Ingrid Müller; James Anthony Cotton; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2022-06-24

5.  Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology.

Authors:  Michael Forgber; Rajatava Basu; Kaushik Roychoudhury; Stephan Theinert; Syamal Roy; Shyam Sundar; Peter Walden
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.

Authors:  Virgínia M G Silva; Cíntia F de-Araújo; Isabela C Navarro; Pablo R S Oliveira; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2015-05-14

7.  Kala-azar in a Brazilian child.

Authors:  Yann A Meunier; Michael K Hole
Journal:  Clin Pract       Date:  2011-04-26

8.  Characterization of Differentially Abundant Proteins Among Leishmania (Viannia) braziliensis Strains Isolated From Atypical or Typical Lesions.

Authors:  Bárbara B Esteves; Marcella N Melo-Braga; Vladimir Gorshkov; Thiago Verano-Braga; Martin R Larsen; Célia M F Gontijo; Patricia F Quaresma; Helida M Andrade
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

9.  Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV.

Authors:  Yegnasew Takele; Tadele Mulaw; Emebet Adem; Caroline Jayne Shaw; Susanne Ursula Franssen; Rebecca Womersley; Myrsini Kaforou; Graham Philip Taylor; Michael Levin; Ingrid Müller; James Anthony Cotton; Pascale Kropf
Journal:  Cell Rep Med       Date:  2021-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.